Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$22.3 - $37.39 $13,380 - $22,434
600 Added 39.74%
2,110 $67,000
Q1 2022

Apr 29, 2022

BUY
$25.68 - $35.59 $16,692 - $23,133
650 Added 75.58%
1,510 $52,000
Q3 2021

Oct 18, 2021

SELL
$25.48 - $37.34 $34,398 - $50,409
-1,350 Reduced 61.09%
860 $22,000
Q2 2021

Aug 06, 2021

SELL
$32.46 - $43.42 $76,605 - $102,471
-2,360 Reduced 51.64%
2,210 $77,000
Q1 2021

Apr 26, 2021

BUY
$38.94 - $50.85 $42,834 - $55,935
1,100 Added 31.7%
4,570 $186,000
Q4 2020

Jan 25, 2021

SELL
$37.65 - $63.77 $41,415 - $70,147
-1,100 Reduced 24.07%
3,470 $150,000
Q3 2020

Oct 20, 2020

BUY
$52.76 - $74.49 $58,036 - $81,939
1,100 Added 31.7%
4,570 $252,000
Q2 2020

Jul 27, 2020

SELL
$48.73 - $81.82 $117,195 - $196,777
-2,405 Reduced 40.94%
3,470 $219,000
Q1 2020

Apr 17, 2020

SELL
$41.72 - $87.2 $5,840 - $12,208
-140 Reduced 2.33%
5,875 $300,000
Q4 2019

Jan 17, 2020

SELL
$45.7 - $81.86 $212,962 - $381,467
-4,660 Reduced 43.65%
6,015 $478,000
Q3 2019

Oct 17, 2019

BUY
$45.35 - $57.91 $96,595 - $123,348
2,130 Added 24.93%
10,675 $518,000
Q4 2018

Jan 17, 2019

BUY
$31.54 - $46.67 $104,082 - $154,011
3,300 Added 62.92%
8,545 $351,000
Q3 2018

Oct 16, 2018

BUY
$38.0 - $51.1 $2,660 - $3,577
70 Added 1.35%
5,245 $199,000
Q1 2018

Apr 10, 2018

SELL
$39.6 - $65.9 $6,930 - $11,532
-175 Reduced 3.27%
5,175 $302,000
Q3 2017

Oct 13, 2017

BUY
$25.1 - $31.05 $134,285 - $166,117
5,350
5,350 $166,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.